antibody

Huntingtin Polyclonal Antibody

MBS448018

0.6 mg

410 USD

polyclonal

goat

nonconjugated

human, rat

western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section

Antibody

Huntingtin Polyclonal Antibody

HTT

Anti-HTT; HD; HTT and IT15 antibody

huntingtin; Huntingtin; huntingtin; huntington disease protein; huntingtin; Huntington disease protein

HTT

HTT; HTT; HD; IT15; HD; IT15; HD protein

HD_HUMAN

Polyclonal

IgG

Goat

Reacts against Human, rat, and mouse proteins

3144

Reacts huntingtin protein, amino acids 85-200. The antibody recognizes wild type and mutant huntingtin.

Polyclonal antibody supplied as (3 mg/ml) aliquot in PBS, 20% glycerol and 0.05% sodium azide. This antibody is epitope-affinity purified from goat antiserum.

For continuous use, store at 2-8 deg C for under one month. For extended storage, store in -20 deg C freezer. Working dilution samples should be discarded if not used within 12 hours. Avoid freeze/ thaw cycles

Immunofluorescence (IF), Western Blot (WB), Immunohistochemistry (IHC) - Paraffin

Western Blot: 1:500-1:2,000. Immunofluorescence: 1:500-1:2,000. Immunohistochemistry (Paraffin): 1:500-1:2,000. Immunohistochemistry (frozen): 1:500-1:2,000

Gene Identifier: ENSG00000197386. Immunogen: Purified recombinant peptide derived from within residues 85 to 200 aa of human HTT produced in E. coli. Antigen: Purified recombinant peptide derived from within residues 85 to 200 aa of human HTT produced in E. coli

Handling: The antibody solution should be gently mixed before use.

Huntingtin. Huntingtin is a protein linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons.

90903231

NP_002102.4

NM_002111.7

P42858

347,603 Da

Direct P53 Effectors Pathway (137939); EGFR1 Signaling Pathway (198782); Huntington's Disease Pathway (83100); Huntington's Disease Pathway (512)

Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range in the number of trinucleotide repeats has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2008]

Function: May play a role in microtubule-mediated transport or vesicle function. Subunit structure: Binds SH3GLB1 . By similarity. Interacts through its N-terminus with PRPF40A. Interacts with PQBP1, SETD2 and SYVN. Interacts with PFN1. Interacts with TPR; the interaction is inhibited by forms of Huntingtin with expanded polyglutamine stretch. Ref.9 Ref.10 Ref.11 Ref.12 Ref.14 Ref.16 Ref.20. Subcellular location: Cytoplasm. Nucleus. Note: The mutant Huntingtin protein colocalizes with AKAP8L in the nuclear matrix of Huntington disease neurons. Shuttles between cytoplasm and nucleus in a Ran GTPase-independent manner. Ref.7 Ref.14 Ref.15. Tissue specificity: Expressed in the brain cortex (at protein level). Widely expressed with the highest level of expression in the brain (nerve fibers, varicosities, and nerve endings). In the brain, the regions where it can be mainly found are the cerebellar cortex, the neocortex, the striatum, and the hippocampal formation. Ref.15. Domain: The N-terminal Gln-rich and Pro-rich domain has great conformational flexibility and is likely to exist in a fluctuating equilibrium of alpha-helical, random coil, and extended conformations. Ref.28. Post-translational modification: Cleaved by apopain downstream of the polyglutamine stretch. The resulting N-terminal fragment is cytotoxic and provokes apoptosis.Forms with expanded polyglutamine expansion are specifically ubiquitinated by SYVN1, which promotes their proteasomal degradation.Phosphorylation at Ser-1179 and Ser-1199 by CDK5 in response to DNA damage in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Polymorphism: The poly-Gln region of HTT is highly polymorphic (10 to 35 repeats) in the normal population and is expanded to about 36-120 repeats in Huntington disease patients. The repeat length usually increases in successive generations, but contracts also on occasion. The adjacent poly-Pro region is also polymorphic and varies between 7-12 residues. Polyglutamine expansion leads to elevated susceptibility to apopain cleavage and likely result in accelerated neuronal apoptosis. Involvement in disease: Huntington disease (HD) [MIM:143100]: A neurodegenerative disorder characterized by involuntary movements (chorea), general motor impairment, psychiatric disorders and dementia. Onset of the disease occurs usually in the third or fourth decade of life. Onset and clinical course depend on the degree of poly-Gln repeat expansion, longer expansions resulting in earlier onset and more severe clinical manifestations. Neuropathology of Huntington disease displays a distinctive pattern with loss of neurons, especially in the caudate and putamen.Note: The disease is caused by mutations affecting the gene represented in this entry. Sequence similarities: Belongs to the huntingtin family.Contains 5 HEAT repeats.

0.6 mg

410 USD